|
|
Blood, 15 November 2003, Vol. 102, No. 10, pp. 3845-3847.
Prepublished online as a Blood First Edition Paper on July 17, 2003; DOI 10.1182/blood-2003-05-1570.
 Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
Brief report
Male DNA in female donor apheresis and CD34-enriched products
Kristina M. Adams,
Nathalie C. Lambert,
Shelly Heimfeld,
Tracy S. Tylee,
Jennifer M. Pang,
Timothy D. Erickson, and
J. Lee Nelson
From the Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA; the Department of Obstetrics and Gynecology, University of Washington, Seattle; School of Medicine, University of Washington, Seattle; and Division of Rheumatology, University of Washington, Seattle.
Increased risk of graft-versus-host disease (GVHD) has been described in recipients of hematopoietic stem cell transplantations when the donor is a parous woman. Cells from prior pregnancies are now known to persist in women and could contribute to GVHD. We asked whether male DNA (presumed fetal microchimerism) is present in apheresis products of female donors. A total of 50 samples were studied by using real-time quantitative polymerase chain reaction (PCR) for the Y chromosome-specific sequence DYS14. Among 29 growth factor-mobilized peripheral blood mononuclear cell (G-PBMC) products, 34% were positive for male DNA. Quantitative results, expressed as DNA genome equivalent of male cells per million host cells (gEq/mil), ranged from 0 to 35 gEq/mil. Among 21 CD34-enriched cell fractions, 48% were positive with a range of 0 to 357 gEq/mil. In summary, male DNA was frequently detected in G-PBMC and CD34-enriched products from female donors. Whether fetal microchimerism contributes to GVHD merits further investigation. (Blood. 2003;102: 3845-3847)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Fujiki, K. L. Johnson, I. Peter, H. Tighiouart, and D. W. Bianchi
Fetal Cells in the Pregnant Mouse Are Diverse and Express a Variety of Progenitor and Differentiated Cell Markers
Biol Reprod,
July 1, 2009;
81(1):
26 - 32.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. O'Donoghue
Fetal microchimerism and maternal health during and after pregnancy
Obstet Med,
December 1, 2008;
1(2):
56 - 64.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Santos, K. O'Donoghue, J. Wyatt-Ashmead, and N. M Fisk
Fetal cells in the maternal appendix: a marker of inflammation or fetal tissue repair?
Hum. Reprod.,
October 1, 2008;
23(10):
2319 - 2325.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Mikhail, H. M'Hamdi, J. Welsh, N. Levicar, S. B. Marley, J. P. Nicholls, N. A. Habib, L. S. Louis, N. M. Fisk, and M. Y. Gordon
High frequency of fetal cells within a primitive stem cell population in maternal blood
Hum. Reprod.,
April 1, 2008;
23(4):
928 - 933.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Khosrotehrani, M. Leduc, V. Bachy, S. N. Huu, M. Oster, A. Abbas, S. Uzan, and S. Aractingi
Pregnancy Allows the Transfer and Differentiation of Fetal Lymphoid Progenitors into Functional T and B Cells in Mothers
J. Immunol.,
January 15, 2008;
180(2):
889 - 897.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Bianchi and N. M. Fisk
Fetomaternal Cell Trafficking and the Stem Cell Debate: Gender Matters
JAMA,
April 4, 2007;
297(13):
1489 - 1491.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. K. Gadi, J. L. Nelson, N. D. Boespflug, K. A. Guthrie, and C. S. Kuhr
Soluble Donor DNA Concentrations in Recipient Serum Correlate with Pancreas-Kidney Rejection
Clin. Chem.,
March 1, 2006;
52(3):
379 - 382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. B. Pedersen, P. Laurberg, N. Knudsen, T. Jorgensen, H. Perrild, L. Ovesen, and L. B. Rasmussen
Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as a trigger of thyroid autoimmunity
Eur. J. Endocrinol.,
January 1, 2006;
154(1):
39 - 45.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. S. Tomas, F. R. Loberiza Jr, J. P. Klein, P. M. Layde, R. J. Lipchik, J. D. Rizzo, C. N. Bredeson, and M. M. Horowitz
Risk Factors for Bronchiolitis Obliterans in Allogeneic Hematopoietic Stem-Cell Transplantation for Leukemia
Chest,
July 1, 2005;
128(1):
153 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Khosrotehrani and D. W. Bianchi
Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse
J. Cell Sci.,
April 15, 2005;
118(8):
1559 - 1563.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ichinohe, T. Uchiyama, C. Shimazaki, K. Matsuo, S. Tamaki, M. Hino, A. Watanabe, M. Hamaguchi, S. Adachi, H. Gondo, et al.
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism
Blood,
December 1, 2004;
104(12):
3821 - 3828.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M. Adams, L. A. Holmberg, W. Leisenring, A. Fefer, K. A. Guthrie, T. S. Tylee, G. B. McDonald, W. I. Bensinger, and J. L. Nelson
Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation
Blood,
September 15, 2004;
104(6):
1894 - 1897.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Khosrotehrani, K. L. Johnson, D. H. Cha, R. N. Salomon, and D. W. Bianchi
Transfer of Fetal Cells With Multilineage Potential to Maternal Tissue
JAMA,
July 7, 2004;
292(1):
75 - 80.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M. Adams and J. L. Nelson
Microchimerism: An Investigative Frontier in Autoimmunity and Transplantation
JAMA,
March 3, 2004;
291(9):
1127 - 1131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
